Abstract
We report on two cases of acute coronary stent thrombosis after early withdrawal of different competitive inhibitors of the platelet glycoprotein IIb/IIIa receptor, eptifibatide and tirofiban. Differences in pharmacokinetics between different types of glycoprotein IIb/IIIa receptor blockers and a potential rebound prothrombotic effect with the use of these antiplatelet drugs are reviewed.
Copyright 2003 Wiley-Liss, Inc.
MeSH terms
-
Acute Disease
-
Angioplasty, Balloon, Coronary / adverse effects*
-
Angioplasty, Balloon, Coronary / methods
-
Catheterization / methods
-
Combined Modality Therapy
-
Coronary Angiography / methods
-
Coronary Restenosis / diagnostic imaging
-
Coronary Restenosis / therapy
-
Coronary Stenosis / diagnostic imaging
-
Coronary Stenosis / therapy*
-
Coronary Thrombosis / diagnostic imaging
-
Coronary Thrombosis / therapy*
-
Electrocardiography
-
Follow-Up Studies
-
Hematoma / diagnostic imaging
-
Hematoma / therapy
-
Humans
-
Male
-
Middle Aged
-
Peritoneal Diseases / diagnostic imaging
-
Peritoneal Diseases / therapy
-
Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use*
-
Risk Assessment
-
Severity of Illness Index
-
Stents / adverse effects*
-
Time Factors
-
Treatment Outcome
Substances
-
Platelet Glycoprotein GPIIb-IIIa Complex